Increasing Influenza Vaccination Rates: The Need to Vaccinate Throughout the Entire Influenza Season

American Journal of Medicine

Volumn 121, Issue 7 SUPPL. 2, 2008, Pages

  Poland, Gregory A ^a   Johnson, David R ^b  

^a MAYO CLINIC   (United States)

^b SANOFI PASTEUR   (France)

Author keywords

Immunization; Influenza; Influenza season; Vaccination

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; DISEASE ACTIVITY; DRUG EFFICACY; DRUG INDUSTRY; DRUG SAFETY; DRUG USE; HEALTH CARE PERSONNEL; HEALTH HAZARD; HOSPITALIZATION; HUMAN; INFECTION RATE; INFLUENZA; INFLUENZA VACCINATION; MEDICAL SOCIETY; MORTALITY; PRIORITY JOURNAL; RISK FACTOR;

HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PRACTICE GUIDELINES AS TOPIC; SEASONS; TIME FACTORS; UNITED STATES; VACCINATION;

EID: 45749126453     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2008.05.002     Document Type: Article

References (61)

1. Centers for Disease Control and Prevention (CDC). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep. 56 RR06 (2007) 1-54
2. Fiore A. Influenza activity in the United States, February 2007. Presented at the Advisory Committee on Immunization Practices, February 21, 2007. http://www.cdc.gov/vaccines/recs/acip/downloads/mtg-slides-feb07/05-influenza-1-allos_fiore.pdf Accessed December 6, 2007
3. Centers for Disease Control and Prevention (CDC). Estimates of influenza vaccination target population sizes in 2006 and recent vaccine uptake levels. www.cdc.gov/flu/professionals/vaccination/pdf/targetpopchart.pdf Accessed December 5, 2007
4. Centers for Disease Control and Prevention (CDC). ACIP provisional recommendations for the prevention and control of influenza. http://www.cdc.gov/vaccines/recs/provisional/downloads/flu-3-21-08-508.pdf Accessed April 3, 2008
5. Reichert T.A., Sugaya N., Fedson D.S., Glezen W.P., Simonsen L., and Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 344 (2001) 889-896
6. Britton T., and Becker N.G. Estimating the immunity coverage required to prevent epidemics in a community of households. Biostatistics 1 (2000) 389-402
7. Monto A.S., and Maassab H.F. Use of influenza vaccine in non-high risk populations. Dev Biol Stand 39 (1977) 329-335
8. Treanor J.J. Influenza virus. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Mandell, Douglass, and Bennett's Principles and Practice of Infectious Diseases. 6th ed. (2005), Elsevier Churchill Livingstone, Philadelphia 2060-2085
9. Cox N.J., and Subbarao K. Influenza. Lancet 354 (1999) 1277-1282
10. Loughlin J., Poulios N., Napalkov P., et al. A study of influenza and influenza-related complications among children in a large US health insurance plan database. Pharmacoeconomics 21 (2003) 273-283
11. Madjid M., Naghavi M., Litovsky S., and Casscells S.W. Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation 108 (2003) 2730-2736
12. Smeeth L., Thomas S.L., Hall A.J., et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 351 (2004) 2611-2618
13. Madjid M., Miller C.C., Zarubaev V.V., et al. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects. Eur Heart J 28 (2007) 1205-1210
14. Centers for Disease Control and Prevention (CDC). Epidemiology and Prevention of Vaccine-Preventable Diseases. 10th ed. In: Atkinson W., Hamborsky J., McIntyre L., and Wolfe S. (Eds) (2007), Public Health Foundation, Washington, DC
15. Kavet J. A perspective on the significance of pandemic influenza. Am J Public Health 67 (1977) 1063-1070
16. Li S., and Leader S. Economic burden and absenteeism from influenza-like illness in healthy households with children (5-17 years) in the US. Respir Med 101 (2007) 1244-1250
17. Keech M., Scott A.J., and Ryan P.J. The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population. Occup Med (Lond) 48 (1998) 85-90
18. Smith A.P., Thomas M., Brockman P., et al. Effect of influenza B virus infection on human performance. BMJ 306 (1993) 760-761
19. Barker W.H., Borisute H., and Cox C. A study of the impact of influenza on the functional status of frail older people. Arch Intern Med 158 (1998) 645-650
20. Thompson W.W., Shay D.K., Weintraub E., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289 (2003) 179-186
21. Thompson W.W., Shay D.K., Weintraub E., et al. Influenza-associated hospitalizations in the United States. JAMA 292 (2004) 1333-1340
22. Miniño A.M., Heron M.P., Murphy S.L., and Kochanek K.D. Deaths: final data for 2004. National Vital Statistics Reports, vol. 55, no. 19 (2007), National Center for Health Statistics, Hyattsville, MD. http://www.cdc.gov/nchs/data/nvsr/nvsr55/nvsr55_19.pdf Accessed January 31, 2008
23. Molinari N.A., Ortega-Sanchez I.R., Messonnier M.L., et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25 (2007) 5086-5096
24. Centers for Disease Control and Prevention (CDC), and National Center for Chronic Disease Prevention and Health Promotion. Costs of chronic disease. November 2005. http://www.cdc.gov/nccdphp/overview.htm#2 Accessed February 9, 2008
25. Bridges C.B., Thompson W.W., Meltzer M.I., et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 284 (2000) 1655-1663
26. Demicheli V., Rivetti D., Deeks J.J., and Jefferson T.O. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 3 (2004) CD001269
27. Nichol K.L., Lind A., Margolis K.L., et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 333 (1995) 889-893
28. Campbell D.S., and Rumley M.H. Cost-effectiveness of the influenza vaccine in a healthy, working-age population. J Occup Environ Med 39 (1997) 408-414
29. Ohmit S.E., Victor J.C., Rotthoff J.R., et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med 355 (2006) 2513-2522
30. Keitel W.A., Cate R.T., Couch R.B., et al. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine 15 (1997) 1114-1122
31. Herrera G.A., Iwane M.K., Cortese M., et al. Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004. Vaccine 25 (2007) 154-160
32. Nichol K.L., Wuorenma J., and von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 158 (1998) 1769-1776
33. Mullooly J.P., Bennett M.D., Hornbrook M.C., et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med 121 (1994) 947-952
34. Jefferson T., Rivetti D., Rudin M., et al. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 366 (2005) 1165-1174
35. Patriarca P.A., Weber J.A., Parker R.A., et al. Efficacy of influenza vaccination in nursing homes: reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA 253 (1985) 1136-1139
36. Arden N.H., Patriarca P.A., and Kendal A.P. Experiences in the use and efficacy of inactivated influenza vaccine in nursing homes. In: Kendal A.P., and Patriarca P.A. (Eds). Options for the Control of Influenza (1986), Alan R. Liss, Inc, New York
37. Monto A.S., Hornbuckle K., and Ohmit S.E. Influenza vaccine effectiveness among elderly nursing home residents: a cohort study. Am J Epidemiol 154 (2001) 155-160
38. Neuzil K.M., Dupont W.D., Wright P.F., and Edwards K.M. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J 20 (2001) 733-740
39. Ritzwoller D.P., Bridges C.B., Shetterly S., et al. Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age with 1 vs. 2 doses. Pediatrics 116 (2005) 153-159
40. Belshe R.B., Mendelman P.M., Treanor J., et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 338 (1998) 1405-1412
41. Belshe R.B., Gruber W.C., Mendelman P.M., et al. Efficacy of vaccination with live-attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Syndney) not contained in the vaccine. J Pediatr 136 (2000) 168-175
42. Margolis K.L., Nichol K.L., Poland G.A., and Pluhar R.E. Frequency of adverse reactions to influenza vaccine in the elderly: a randomized, placebo-controlled trial. JAMA 264 (1990) 1139-1141
43. Centers for Disease Control and Prevention (CDC). National Immunization Program: record of the meeting of the Advisory Committee on Immunization Practices, February 21-22, 2006. http://www.cdc.gov/vaccines/recs/acip/downloads/min-feb06.pdf Accessed February 29, 2008
44. US Department of Health and Human Services. Healthy people [Healthy People 2010 Web site]. http://www.healthypeople.gov Accessed March 3, 2008
45. Poland G.A., Ofstead C.L., Tucker S.J., and Beebe T.J. Receptivity to mandatory influenza vaccination policies for healthcare workers among registered nurses working on inpatient units. Infect Control Hosp Epidemiol 29 (2008) 170-173
46. Adler G.S. Influenza vaccination and self-reported reasons for not receiving influenza vaccination among Medicare beneficiaries aged ≥65 years: United States, 1991-2002. MMWR Morb Mortal Wkly Rep 53 (2004) 1012-1015
47. National Foundation for Infectious Diseases. Public perception of influenza, vaccination and treatment options: national consumer survey sponsored by the National Foundation for Infectious Diseases (NFID). http://www.connectlive.com/events/infectiousdiseases/presskit2006/Survey%20Results%20Fact%20Sheet%20092706.pdf Accessed February 9, 2008
48. Tucker S.J., Poland G.A., and Jacobson R.M. Requiring influenza vaccination for health care workers. Am J Nurs 108 (2008) 32-34
49. Poland G.A., and Jacobson R.M. Protecting patients from harm: legislating vaccinations for healthcare workers. Am J Prev Med 32 (2007) 544-546
50. Lin C.J., Nowalk M.P., Zimmerman R.K., et al. Beliefs and attitudes about influenza immunization among parents of children with chronic medical conditions over a two-year period. J Urban Health 83 (2006) 874-883
51. Lewis-Parmar H., and McCann R. Achieving national influenza vaccine targets: an investigation of the factors affecting influenza vaccine uptake in older people and people with diabetes. Commun Dis Public Health 5 (2002) 119-126
52. Johnson D.R., Nichol K.L., and Lipczynski K. Barriers to adult immunization. Am J Med 121 (2008) S28-S35
53. Stinchfield P.K. Practice-proven interventions to increase vaccination rates and broaden the immunization season. Am J Med 121 (2008) S11-S21
54. Fishbein D.B., Fontanesi J., Kopald D., et al. Why do not patients receive influenza vaccine in December and January?. Vaccine 24 (2006) 798-802
55. American Medical Association. The National Influenza Vaccine Summit home page. http://www.ama-assn.org/ama/pub/category/13732.html Accessed December 4, 2007
56. American Lung Association. Faces of influenza: vaccination recommendations [American Lung Association Web site factsheet]. http://www.facesofinfluenza.org/resources/2007/Recommendations_FactSheet_2007.pdf Accessed December 4, 2007
57. National Foundation for Infectious Diseases. Influenza overview/introduction. http://www.nfid.org/influenza Accessed December 4, 2007
58. Wallace G.S. Vaccine supply. Presented at the Advisory Committee on Immunization Practices, February 27, 2008; Atlanta, Georgia. http://www.cdc.gov/vaccines/recs/acip/downloads/mtg-slides-feb08/23-vac-supply.pdf Accessed December 7, 2007
59. Brokstad K.A., Cox R.J., Olofsson J., et al. Parenteral influenza vaccination induces a rapid systemic and local immune response. J Infect Dis 171 (1995) 198-203
60. Gross P.A., Russo C., Dran S., et al. Time to earliest peak serum antibody response to influenza vaccine in the elderly. Clin Diagn Lab Immunol 4 (1997) 491-492
61. Centers for Disease Control and Prevention (CDC). Breaking from your comfort zone: extending the influenza vaccination season [PowerPoint slide presentation]. www.cdc.gov/vaccines/ed/ciinc/calls/flucall.htm Accessed December 6, 2007